| Jul 9 2024 |
FDA Issues Long-Anticipated Draft Guidance on Diversity Action Plans |
Epstein Becker & Green, P.C. |
| Jul 9 2024 |
Recent Federal and State Reproductive Health Developments |
Greenberg Traurig, LLP |
| Jul 9 2024 |
This Week in 340B: July 2 – 8, 2024 |
McDermott Will & Schulte LLP |
| Jul 9 2024 |
Two Chinese Food Agencies Release Drafts of New Food Labeling Requirements |
Keller and Heckman LLP |
| Jul 8 2024 |
APHIS Issues Regulatory Status Review Responses |
Bergeson & Campbell, P.C. |
| Jul 8 2024 |
DOJ to Ramp up Antitrust Enforcement in Agriculture Sector |
Foley & Lardner LLP |
| Jul 8 2024 |
Petition for Certiorari Filed in Supreme Court in False Claims Act Case Seeking Review of Whether “Willful” Under the Anti-Kickback Statute Requires Knowledge that the Conduct is Unlawful |
Mintz |
| Jul 6 2024 |
USDA Publishes RFI on the Production of Biofuel Feedstocks Using Climate-Smart Practices |
Bergeson & Campbell, P.C. |
| Jul 6 2024 |
NIOSH Highlights NTRC’s Work on Engineering Controls and PPE |
Bergeson & Campbell, P.C. |
| Jul 5 2024 |
Urinary Catheter Fraud Sparks Proposed Medicare Payment Changes for ACOS |
K&L Gates LLP |
| Jul 5 2024 |
WHALE HUNTING: Temu Facing Another TCPA Class Action After Its Arbitration Clause Deemed Unenforceable |
Troutman Amin, LLP |
| Jul 3 2024 |
NNI and NNCO Will Hold July 24 Workshop on “Responsible Development, Social Science, and the National Nanotechnology Initiative” |
Bergeson & Campbell, P.C. |
| Jul 3 2024 |
This Week in 340B: June 28 – July 1, 2024 |
McDermott Will & Schulte LLP |
| Jul 3 2024 |
Loper Bright Could Shift Outlook for FDA Legal Challenges |
McDermott Will & Schulte LLP |
| Jul 3 2024 |
FDA Authorizes First Menthol-Flavored Vapor Products |
Keller and Heckman LLP |
| Jul 3 2024 |
Chobani Petitions FDA to Amend Yogurt Standard of Identity |
Keller and Heckman LLP |
| Jul 3 2024 |
EPA Announces Final Cancellation Order and Updates to Existing Stocks Provisions for Several Chlorpyrifos Products |
Bergeson & Campbell, P.C. |
| Jul 2 2024 |
Federal Circuit Clarifies Rules for Skinny Labelling for Generics and Biosimilar Companies |
Polsinelli PC |
| Jul 2 2024 |
Healthcare Execs Face Federal Drug Charges in Landmark Telehealth Case |
Bradley Arant Boult Cummings LLP |
| Jul 2 2024 |
FDA to Revoke Authorization for Brominated Vegetable Oil in Food |
Keller and Heckman LLP |
| Jul 2 2024 |
Unpacking Averages: Intended Use Words Most Common to Devices That Require Clinical Trials |
Epstein Becker & Green, P.C. |
| Jul 1 2024 |
Ten Things CPG Companies Should Do to Manage Co-Manufacturer Relationships |
K&L Gates LLP |
| Jul 1 2024 |
We Get Work: Life Sciences and Real-World Accommodation Scenarios [Podcast] |
Jackson Lewis P.C. |
| Jul 1 2024 |
It Ain’t Over ‘til It’s Over: IRS Reminds Taxpayers That Section 280E Applies to Marijuana Companies Until Rescheduling Becomes Law |
Bradley Arant Boult Cummings LLP |
| Jun 29 2024 |
Cheers to this! Good News for the North Carolina Alcoholic Beverage Industry |
Ward and Smith, P.A. |
| Jun 28 2024 |
Biden-Harris Administration Announces Actions to Accelerate U.S. Domestic Biomanufacturing Capacity |
Bergeson & Campbell, P.C. |
| Jun 28 2024 |
Minnesota Department of Health Highlights Recent Publications on PFAS Bioaccumulation and PFAS in Infant Formula |
Bergeson & Campbell, P.C. |
| Jun 28 2024 |
Old North State Report – June 28, 2024 |
Nelson Mullins |
| Jun 28 2024 |
In Purdue Pharma, the Supreme Court Fires a Canon of Construction Through Non-Consensual Third-Party Releases (US) |
Squire Patton Boggs (US) LLP |
| Jun 28 2024 |
FDA Releases Update of Priority Guidance Topics for Foods Program |
Keller and Heckman LLP |
| Jun 28 2024 |
Codifying the Experimental Use Exception? USPTO Seeks Public Input |
Womble Bond Dickinson (US) LLP |
| Jun 28 2024 |
SCOTUS Update: Supreme Court Clarifies Organizational Standing in FDA-Related Ruling |
ArentFox Schiff LLP |
| Jun 27 2024 |
In Purdue Pharma, Supreme Court Rules That Nonconsensual Releases Are A Nonstarter |
Miller Canfield |
| Jun 27 2024 |
Aye, What’s the Deal with THCA? Unraveling Hemp’s Legal Knots |
Norris McLaughlin P.A. |
| Jun 27 2024 |
E for Effort? PI Analysis in Trade Secret Suit Riddled with Errors |
McDermott Will & Schulte LLP |
